Humana Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Humana (HUM)
Idag, 21:52
Idag, 21:52
Humana Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Humana (HUM)
PR Newswire
NEW YORK, Nov. 19, 2026
Selling your HUM shares after the November 18 Medicare Advantage selloff does not necessarily end your rights. SueWallSt notifies investors of a pending investigation into whether Humana adequately disclosed its exposure to Medicare Advantage audit and repayment risk.
NEW YORK , Nov. 19, 2026 /PRNewswire/ -- Humana Inc. (NYSE: HUM) shareholders lost more than 12% of their position's value on November 18, 2026, after reports of a proposed federal CRUSH rule targeting fraud , waste, and improper payments in Medicare Advantage. Whether you still hold HUM or already sold at a loss, you may have the right to seek recovery. Shareholders who lost money are encouraged to report your Humana losses here before the investigation moves forward. You may also contact Joseph E. Levi, Esq. via email at jlevi@SueWallSt.com or by telephone at (888) SueWallSt.

Early reports on November 18 showed HUM down 3.95% at $443.12. Later reports put the decline at more than 12.9%. The proposal reportedly calls for stronger Medicare Advantage audits and expanded recovery of unsupported risk-adjustment payments.
SueWallSt notifies investors of a pending investigation into potential securities law violations, including whether Humana's public disclosures adequately addressed its Medicare Advantage audit and repayment exposure. Your right to participate depends on when you bought, not on whether you still own the shares. There is no cost to have your losses reviewed.
If you bought Humana stock and are now facing a loss, find out whether you may be entitled to recover . You may also reach Joseph E. Levi, Esq. at jlevi@SueWallSt.com or (888) SueWallSt.
WHY SUEWALLST : SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured billions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
Frequently Asked Questions About the HUM Investigation
Q: Who is eligible to participate in the HUM investigation? A: Investors who purchased HUM stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What if I already sold my HUM shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought HUM and sold at a loss may still participate in the investigation.
Q: How much did HUM stock drop? A: Shares fell more than 12.9% on November 18, 2026, following reports of a proposed federal rule calling for stronger Medicare Advantage audits and expanded recovery of unsupported risk-adjustment payments. Investors who purchased HUM shares and suffered losses may be eligible to seek compensation.
Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Humana's public statements adequately addressed its exposure to Medicare Advantage audits, risk-adjustment payment reviews, and potential repayment obligations. When reports of a proposed federal Medicare Advantage audit crackdown emerged on November 18, 2026, the stock price declined sharply.
Q: What do HUM investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery . No immediate action is required to remain eligible to participate in the investigation.
Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@SueWallSt.com
Tel: (888) SueWallSt
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
View original content to download multimedia: https://www.prnewswire.com/news-releases/humana-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-humana-hum-302946046.html
SOURCE SueWallSt.com
Idag, 21:52
Humana Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Humana (HUM)
PR Newswire
NEW YORK, Nov. 19, 2026
Selling your HUM shares after the November 18 Medicare Advantage selloff does not necessarily end your rights. SueWallSt notifies investors of a pending investigation into whether Humana adequately disclosed its exposure to Medicare Advantage audit and repayment risk.
NEW YORK , Nov. 19, 2026 /PRNewswire/ -- Humana Inc. (NYSE: HUM) shareholders lost more than 12% of their position's value on November 18, 2026, after reports of a proposed federal CRUSH rule targeting fraud , waste, and improper payments in Medicare Advantage. Whether you still hold HUM or already sold at a loss, you may have the right to seek recovery. Shareholders who lost money are encouraged to report your Humana losses here before the investigation moves forward. You may also contact Joseph E. Levi, Esq. via email at jlevi@SueWallSt.com or by telephone at (888) SueWallSt.

Early reports on November 18 showed HUM down 3.95% at $443.12. Later reports put the decline at more than 12.9%. The proposal reportedly calls for stronger Medicare Advantage audits and expanded recovery of unsupported risk-adjustment payments.
SueWallSt notifies investors of a pending investigation into potential securities law violations, including whether Humana's public disclosures adequately addressed its Medicare Advantage audit and repayment exposure. Your right to participate depends on when you bought, not on whether you still own the shares. There is no cost to have your losses reviewed.
If you bought Humana stock and are now facing a loss, find out whether you may be entitled to recover . You may also reach Joseph E. Levi, Esq. at jlevi@SueWallSt.com or (888) SueWallSt.
WHY SUEWALLST : SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured billions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
Frequently Asked Questions About the HUM Investigation
Q: Who is eligible to participate in the HUM investigation? A: Investors who purchased HUM stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What if I already sold my HUM shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought HUM and sold at a loss may still participate in the investigation.
Q: How much did HUM stock drop? A: Shares fell more than 12.9% on November 18, 2026, following reports of a proposed federal rule calling for stronger Medicare Advantage audits and expanded recovery of unsupported risk-adjustment payments. Investors who purchased HUM shares and suffered losses may be eligible to seek compensation.
Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Humana's public statements adequately addressed its exposure to Medicare Advantage audits, risk-adjustment payment reviews, and potential repayment obligations. When reports of a proposed federal Medicare Advantage audit crackdown emerged on November 18, 2026, the stock price declined sharply.
Q: What do HUM investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery . No immediate action is required to remain eligible to participate in the investigation.
Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@SueWallSt.com
Tel: (888) SueWallSt
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
View original content to download multimedia: https://www.prnewswire.com/news-releases/humana-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-humana-hum-302946046.html
SOURCE SueWallSt.com
Anthropics IPO
Anthropics IPO
1 DAG %
Senast
OMX Stockholm 30
0,02%
(vid stängning)
USA
Idag, 16:28
Fler arbetssökanden än väntat i USA
OMX Stockholm 30
1 DAG %
Senast
3 256,72